001     283165
005     20240229155050.0
024 7 _ |a 10.1126/scisignal.abl8266
|2 doi
024 7 _ |a pmid:37751479
|2 pmid
024 7 _ |a 1945-0877
|2 ISSN
024 7 _ |a 1525-8882
|2 ISSN
024 7 _ |a 1937-9145
|2 ISSN
024 7 _ |a altmetric:154671512
|2 altmetric
037 _ _ |a DKFZ-2023-01948
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Adam, Lukas
|b 0
245 _ _ |a Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells.
260 _ _ |a Washington, DC [u.a.]
|c 2023
|b Assoc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1695974302_24400
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:B330#
520 _ _ |a Virus-host interactions can reveal potentially effective and selective therapeutic targets for treating infection. Here, we performed an integrated analysis of the dynamics of virus replication and the host cell transcriptional response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using human Caco-2 colon cancer cells as a model. Time-resolved RNA sequencing revealed that, upon infection, cells immediately transcriptionally activated genes associated with inflammatory pathways that mediate the antiviral response, which was followed by an increase in the expression of genes involved in ribosome and mitochondria function, thus suggesting rapid alterations in protein production and cellular energy supply. At later stages, between 24 and 48 hours after infection, the expression of genes involved in metabolic processes-in particular, those related to xenobiotic metabolism-was decreased. Mathematical modeling incorporating SARS-CoV-2 replication suggested that SARS-CoV-2 proteins inhibited the host antiviral response and that virus transcripts exceeded the translation capacity of the host cells. Targeting kinase-dependent pathways that exhibited increases in transcription in host cells was as effective as a virus-targeted inhibitor at repressing viral replication. Our findings in this model system delineate a sequence of SARS-CoV-2 virus-host interactions that may facilitate the identification of druggable host pathways to suppress infection.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Stanifer, Megan
|b 1
700 1 _ |a Springer, Fabian
|b 2
700 1 _ |a Mathony, Jan
|0 0000-0003-4081-9953
|b 3
700 1 _ |a Brune, Maik
|b 4
700 1 _ |a Di Ponzio, Chiara
|b 5
700 1 _ |a Eils, Roland
|b 6
700 1 _ |a Boulant, Steeve
|0 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
|b 7
700 1 _ |a Niopek, Dominik
|b 8
700 1 _ |a Kallenberger, Stefan
|0 P:(DE-He78)7250cfa9e9bf9ac1eeafa31eb9d043c1
|b 9
|e Last author
|u dkfz
773 _ _ |a 10.1126/scisignal.abl8266
|g Vol. 16, no. 804, p. eabl8266
|0 PERI:(DE-600)2417226-1
|n 804
|p eabl8266
|t Science signaling
|v 16
|y 2023
|x 1945-0877
909 C O |p VDB
|o oai:inrepo02.dkfz.de:283165
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)7250cfa9e9bf9ac1eeafa31eb9d043c1
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-16
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-16
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI SIGNAL : 2022
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b SCI SIGNAL : 2022
|d 2023-08-19
920 2 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 0
920 1 _ |0 I:(DE-He78)F140-20160331
|k F140
|l NWG Infection and Immune Sensing Dynamics
|x 0
920 1 _ |0 I:(DE-He78)B330-20160331
|k B330
|l Angewandte Bioinformatik
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F140-20160331
980 _ _ |a I:(DE-He78)B330-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21